Sun Pharmaceuticals reported INR31.98B in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aspen Pharmacare APN:SJ ZAR 4.58B 1.07B
Bharat Petroleum BPCL:IN INR 14.15B 62.73B
Cipla CIPLA:IN INR 13.02B 1.59B
Dr.Reddys Laboratories DRRD:IN INR 19.01B 9.6B
Reliance Infra RELI:IN INR 312.24B 67.73B
Sun Pharmaceuticals SUNP:IN INR 31.98B 4.59B
UPL UPLL:IN INR 27.68B 4.25B